Hiv
2,071
203
294
1,341
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
388 trials with published results (19%)
Research Maturity
1341 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.4%
71 terminated out of 2071 trials
95.0%
+8.5% vs benchmark
14%
284 trials in Phase 3/4
29%
388 of 1341 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1341 completed trials
Clinical Trials (2071)
Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Zn Supplementation in HIV Immunological Non Responders
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2
Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers
Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services
The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV
IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care
Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
The Collaborative Care PrTNER Study
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Tissue Biopsy and Imaging Studies in HIV-Infected Patients
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Viral Load in Blood and Lymph Tissues in People Living With HIV
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
HIV Prevention and Care Engagement in Nepal
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1